Extended Versus Standard Pouch in Roux-en-Y Gastric Bypass: Five To Nine Year Follow-Up Results of a Randomized Controlled Trial

• by Mitchell J. R. Harker, Sietske Okkema, Maud Schuurman, Laura Heusschen, Guusje Vugts, Eric J. Hazebroek

• February 13, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

The Future of Obesity Care: Exploring Synergies Between Metabolic Bariatric Surgery, Interventional Endoscopy and Pharmacotherapy

• by Wendy A. Brown, Priya Sumithran, Michael Cowley, Ricardo Cohen, Carel Le Roux, Philip Schauer, Santosh Agarwal, Jamie Ard, Camilo Boza, Jenny Lynn Cargiuolo, Letizia Ceccarelli, Jake Coverdale, Brian Dunkin, Francis Finucane, Kapil Gupta, Lee M. Kaplan, Marina Kurian, Ildiko Lingvay, Alex Miras, Chuck Pearlman, Terissa Petry, Dimitri Pournaras, Jonthan Purnell, Roxana Ruiz, Carlos Schiavon, Abd Tahrani, Hanan Tarek, Jorg Tomaszewski, Sascha Tumik, Ramy Younes

• May 4, 2026

Early Enteral Feeding Tied to Fewer Complications

Benefit driven by fewer infections and pulmonary events, though overall complication rates were similar

• by Kathryn Wighton

• May 1, 2026

• 5 min